PortfoliosLab logoPortfoliosLab logo
LABD vs. GEVG
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

LABD vs. GEVG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Leverage Shares 2X Long GEV Daily ETF (GEVG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LABD achieves a -53.78% return, which is significantly lower than GEVG's 112.16% return.


LABD

1D
-3.10%
1M
-32.29%
YTD
-53.78%
6M
-50.39%
1Y
-87.04%
3Y*
-56.99%
5Y*
-43.25%
10Y*
-59.09%

GEVG

1D
-16.17%
1M
-5.00%
YTD
112.16%
6M
107.42%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

LABD vs. GEVG - Yearly Performance Comparison


Correlation

The correlation between LABD and GEVG is -0.41, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (All Time)
Calculated using the full available price history since Dec 16, 2025

-0.41

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LABD vs. GEVG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABD
LABD Risk / Return Rank: 11
Overall Rank
LABD Sharpe Ratio Rank: 11
Sharpe Ratio Rank
LABD Sortino Ratio Rank: 00
Sortino Ratio Rank
LABD Omega Ratio Rank: 00
Omega Ratio Rank
LABD Calmar Ratio Rank: 00
Calmar Ratio Rank
LABD Martin Ratio Rank: 22
Martin Ratio Rank

GEVG

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LABD vs. GEVG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Leverage Shares 2X Long GEV Daily ETF (GEVG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LABDGEVGDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.70

Calmar ratioReturn relative to maximum drawdown

-1.00

Martin ratioReturn relative to average drawdown

-1.37

LABD vs. GEVG - Sharpe Ratio Comparison


Loading charts...

Drawdowns

LABD vs. GEVG - Drawdown Comparison

The maximum LABD drawdown since its inception was -99.99%, which is greater than GEVG's maximum drawdown of -45.50%. Use the drawdown chart below to compare losses from any high point for LABD and GEVG.


Loading charts...

Drawdown Indicators


LABDGEVGDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-45.50%

-54.49%

Max Drawdown (1Y)

Largest decline over 1 year

-86.75%

Max Drawdown (3Y)

Largest decline over 3 years

-96.40%

Max Drawdown (5Y)

Largest decline over 5 years

-98.65%

Max Drawdown (10Y)

Largest decline over 10 years

-99.99%

Current Drawdown

Current decline from peak

-99.99%

-24.03%

-75.96%

Average Drawdown

Average peak-to-trough decline

-90.99%

-11.33%

-79.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

64.00%

Volatility

LABD vs. GEVG - Volatility Comparison


Loading charts...

Volatility by Period


LABDGEVGDifference

Volatility (1M)

Calculated over the trailing 1-month period

29.98%

Volatility (6M)

Calculated over the trailing 6-month period

65.23%

Volatility (1Y)

Calculated over the trailing 1-year period

78.79%

101.04%

-22.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

96.66%

101.04%

-4.38%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

95.97%

101.04%

-5.07%

LABD vs. GEVG - Expense Ratio Comparison

LABD has a 1.06% expense ratio, which is higher than GEVG's 0.75% expense ratio.


Dividends

LABD vs. GEVG - Dividend Comparison

LABD's dividend yield for the trailing twelve months is around 9.79%, while GEVG has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018
GEVG
Leverage Shares 2X Long GEV Daily ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LABD
Direxion Daily S&P Biotech Bear 3x Shares
9.79%6.67%4.68%6.13%0.53%0.00%3.94%1.75%0.81%

Frequently Asked Questions


LABD and GEVG have a correlation of -0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, GEVG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

GEVG is cheaper with a 0.75% expense ratio, compared with 1.06% for LABD.

LABD has the higher dividend yield at 9.79%, compared with 0.00% for GEVG.

They also come from different issuers: Direxion and Leverage Shares. Their fees differ too: 1.06% for LABD and 0.75% for GEVG.

Portfolio Optimizer

Find the right allocation for LABD and GEVG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer